Straightforward molecular tests for predicting response and non-response to platinum-based neoadjuvant therapy in high-grade serous ovarian cancer patients

被引：0
|
作者：
Imyanitov, E. N. [1 ]
Sokolenko, A. [1 ]
Gorodnova, T. [2 ]
Bizin, I. V. [1 ]
Kuligina, E. S. [1 ]
Kotiv, K. [2 ]
Romanko, A. [1 ]
Ermachenkova, T. [1 ]
Ivantsov, A. O. [1 ]
Preobrazhenskaya, E. [1 ]
Sokolova, T. [1 ]
Aleksakhina, S. [1 ]
Broyde, R. [3 ]
Berlev, I.
机构：
[1] NN Petrov Inst Oncol, Dept Tumor Growth Biol, St Petersburg, Russia
[2] NN Petrov Inst Oncol, Dept Gynaecol, St Petersburg, Russia
[3] City Canc Ctr, Dept Chemotherapy, St Petersburg, Russia
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1016/j.annonc.2021.08.1202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
760P
引用
收藏
页码：S748 / S748
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy for high-grade serous ovarian cancer: radiologic-pathologic correlation of response assessment and predictors of progression
    Roseland, Molly E.
    Ma, Tianwen
    Shampain, Kimberly L.
    Stein, Erica B.
    Wasnik, Ashish P.
    Curci, Nicole E.
    Sciallis, Andrew P.
    Uppal, Shitanshu
    Johnson, Timothy D.
    Maturen, Katherine E.
    ABDOMINAL RADIOLOGY, 2024, 49 (06) : 2040 - 2048
  • [42] COMPREHENSIVE CHARACTERIZATION OF NAIVE TREATMENT SAMPLES OF HIGH GRADE SEROUS OVARIAN CANCER ADDRESSED TO NEOADJUVANT CHEMOTHERAPY: A HYPOTHESIS-GENERATING STUDY ON BIOMARKERS OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY
    Trozzi, Rita
    Nero, Camilla
    Duranti, Simona
    Giacomini, Flavia
    Marino, Ilenia
    Camarda, Floriana
    Anderson, Gloria
    Pasciuto, Tina
    Giaco, Luciano
    Casu, Paolo
    Giannarelli, Diana
    Fagotti, Anna
    Lorusso, Domenica
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A312 - A313
  • [43] NEOADJUVANT CHEMOTHERAPY MAY IMPAIR RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN CANCER PATIENTS
    Ekmann-Gade, A. W.
    Hogdall, C.
    Peen, U. B. S.
    Engelholm, S. A.
    Fago-Olsen, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 675 - 676
  • [44] Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study
    Bi, Qiu
    Miao, Kun
    Xu, Na
    Hu, Faping
    Yang, Jing
    Shi, Wenwei
    Lei, Ying
    Wu, Yunzhu
    Song, Yang
    Ai, Conghui
    Li, Haiming
    Qiang, Jinwei
    ACADEMIC RADIOLOGY, 2024, 31 (06) : 2367 - 2380
  • [45] Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Rundo, Leonardo
    Beer, Lucian
    Escudero Sanchez, Lorena
    Crispin-Ortuzar, Mireia
    Reinius, Marika
    McCague, Cathal
    Sahin, Hilal
    Bura, Vlad
    Pintican, Roxana
    Zerunian, Marta
    Ursprung, Stephan
    Allajbeu, Iris
    Addley, Helen
    Martin-Gonzalez, Paula
    Buddenkotte, Thomas
    Singh, Naveena
    Sahdev, Anju
    Funingana, Ionut-Gabriel
    Jimenez-Linan, Mercedes
    Markowetz, Florian
    Brenton, James D.
    Sala, Evis
    Woitek, Ramona
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
    Stanske, Mandy
    Wienert, Stephan
    Castillo-Tong, Dan Cacsire
    Kreuzinger, Caroline
    Vergote, Ignace
    Lambrechts, Sandrijne
    Gabra, Hani
    Gourley, Charlie
    Ganapathi, Ram N.
    Kolaschinski, Ivonne
    Budczies, Jan
    Sehouli, Jalid
    Ruscito, Ilary
    Denkert, Carsten
    Kulbe, Hagen
    Schmitt, Wolfgang
    Johrens, Korinna
    Braicu, Ioana
    Darb-Esfahani, Silvia
    NEOPLASIA, 2018, 20 (03): : 280 - 288
  • [47] Phylogenetic and signature analyses predict treatment response in high-grade serous ovarian cancer
    Oikkonen, Jaana
    Li, Yilin
    Alkodsi, Amjad
    Carpen, Olli
    Huhtinen, Kaisa
    Hietanen, Sakari
    Grenman, Seija E.
    Lehtonen, Rainer
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients
    Bartl, Thomas
    Karacs, Jasmine
    Kreuzinger, Caroline
    Pfaffinger, Stephanie
    Kendler, Jonatan
    Ciocsirescu, Cristina
    Wolf, Andrea
    Reinthaller, Alexander
    Meyer, Elias
    Brandstetter, Maximilian
    Postl, Magdalena
    Langthaler, Eva
    Braicu, Elena
    Vergote, Ignace
    Cunnea, Paula
    Gourley, Charlie
    Schmitt, Wolfgang D.
    Cacsire Castillo-Tong, Dan
    Christoph, Grimm
    CANCERS, 2021, 13 (05) : 1 - 14
  • [49] Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer
    Wang, Wei
    Wang, Jinshu
    Zhang, Xinzhong
    Liu, Gang
    ONCOTARGETS AND THERAPY, 2019, 12 : 7451 - 7457
  • [50] Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer
    Piedimonte, Sabrina
    Kim, Rachel
    Bernardini, Marcus Q.
    Atenafu, Eshetu G.
    Clark, Mitchell
    Lheureux, Stephanie
    May, Taymaa
    GYNECOLOGIC ONCOLOGY, 2022, 167 (03) : 417 - 422
12345